The KCNA2 gene early infantile epileptic encephalopathy type 32 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the KCNA2 gene, which are associated with early infantile epileptic encephalopathy type 32 (EIEE32). This condition is a severe form of epilepsy that manifests in the first few months of life, characterized by frequent seizures and significant developmental delays. The test plays a crucial role in the early detection and management of this condition, allowing for tailored treatment plans that can improve the quality of life for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA to look for specific genetic alterations in the KCNA2 gene that are linked to EIEE32. This state-of-the-art lab ensures accurate and reliable results, leveraging advanced genetic sequencing technologies.
The cost of the KCNA2 gene early infantile epileptic encephalopathy type 32 genetic test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive process of sample collection, DNA extraction, sequencing, and expert analysis, providing families with crucial information regarding the genetic underpinnings of the condition. Early diagnosis through this test can significantly impact the management strategies for affected infants, paving the way for interventions that can mitigate the severity of symptoms and promote better developmental outcomes.
The STXBP1 gene is associated with early infantile epileptic encephalopathy type 4 (EIEE4), a severe neurological disorder characterized by early-onset seizures and developmental delays. Genetic testing for mutations in the STXBP1 gene is crucial for diagnosing this condition, enabling early intervention and personalized management strategies for affected individuals.
DNA Labs UAE offers a comprehensive genetic test targeting the STXBP1 gene to identify mutations that may lead to EIEE4. The test is designed to provide accurate and reliable results, which are essential for the diagnosis and treatment planning of this epileptic encephalopathy. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed.
By opting for this genetic test, families and healthcare providers can gain valuable insights into the genetic underpinnings of the condition, facilitating informed decisions about care and support for those affected by EIEE4.
The GRIN2D gene plays a crucial role in the functioning of the nervous system, encoding a subunit of NMDA receptors that are involved in synaptic transmission and plasticity in the brain. Mutations in the GRIN2D gene have been associated with early infantile epileptic encephalopathy type 46 (EIEE46), a severe form of epilepsy that manifests in infancy. This condition is characterized by frequent seizures that are resistant to treatment, developmental delays, and other neurological issues.
To diagnose this genetic condition, DNA Labs UAE offers a specialized genetic test targeting the GRIN2D gene. The test is designed to identify mutations in the GRIN2D gene that are linked to EIEE46, providing crucial information for the diagnosis and management of the condition. Early diagnosis through genetic testing can help in managing the symptoms more effectively and can guide treatment decisions.
The cost of the GRIN2D gene test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the GRIN2D gene. Results from this test can provide valuable insights into the genetic basis of the patient's condition, aiding in the development of a personalized treatment plan.
Families with a history of EIEE46 or who have a child showing symptoms consistent with early infantile epileptic encephalopathy may consider this genetic test as part of their diagnostic journey. DNA Labs UAE ensures a comprehensive analysis, providing families and healthcare providers with critical information to support those affected by this challenging condition.
The FGF12 gene, associated with early infantile epileptic encephalopathy type 47 (EIEE47), plays a crucial role in the normal development and function of the nervous system. Mutations in the FGF12 gene can lead to severe neurological conditions characterized by early-onset seizures, developmental delays, and various other neurological abnormalities. Given the critical nature of timely and accurate diagnosis for managing such conditions, genetic testing for mutations in the FGF12 gene becomes indispensable.
DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the FGF12 gene to confirm a diagnosis of early infantile epileptic encephalopathy type 47. This test is particularly vital for families with a history of the condition or for infants presenting symptoms consistent with EIEE47. Early diagnosis through this genetic test can facilitate prompt intervention and management strategies, potentially improving outcomes and quality of life for affected individuals.
The cost of the FGF12 gene test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect any mutations in the FGF12 gene that could be indicative of EIEE47. Conducted in a state-of-the-art laboratory by experienced geneticists, the test adheres to stringent quality and accuracy standards, ensuring reliable results for patients and their families.
The SPTAN1 Gene Early Infantile Epileptic Encephalopathy Type 5 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the SPTAN1 gene. These mutations are associated with Early Infantile Epileptic Encephalopathy Type 5 (EIEE5), a rare but severe form of epilepsy that emerges in infancy. EIEE5 is characterized by frequent seizures, developmental delays, and various neurological impairments, making early diagnosis crucial for managing symptoms and improving quality of life.
This genetic test involves analyzing the patient's DNA to identify specific mutations in the SPTAN1 gene that are known to cause EIEE5. By pinpointing these mutations, healthcare providers can confirm a diagnosis of EIEE5, allowing for tailored treatment plans and genetic counseling for affected families.
The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of results. This test is particularly important for families with a history of EIEE5 or unexplained infantile seizures, as it provides essential genetic insights that can guide clinical decisions and support.
The SCN1A gene is critical in the proper functioning of brain cells, and mutations in this gene can lead to a range of epileptic disorders, including Early Infantile Epileptic Encephalopathy Type 6 (EIEE6). EIEE6 is a severe form of epilepsy that emerges in the first few months of life, characterized by frequent seizures and significant developmental delays. Genetic testing for mutations in the SCN1A gene is essential for diagnosing EIEE6, guiding treatment options, and providing information on the condition's prognosis.
DNA Labs UAE offers a specialized genetic test to identify mutations in the SCN1A gene associated with Early Infantile Epileptic Encephalopathy Type 6. This test is a vital tool for families seeking answers about this challenging condition. The cost of the SCN1A gene test at DNA Labs UAE is 4400 AED. By conducting this test, healthcare professionals can confirm the diagnosis of EIEE6, enabling them to tailor a treatment plan that can potentially improve the quality of life for affected infants and provide families with crucial information regarding the condition's management and outlook.
The TUBB4A gene DYT4 genetic test is a specialized diagnostic tool designed to identify mutations in the TUBB4A gene, which are linked to DYT4 dystonia, a rare genetic disorder characterized by abnormal muscle tone and involuntary muscle contractions leading to repetitive movements or abnormal postures. DYT4 dystonia, also known as "whispering dysphonia," is one of the many forms of dystonia, affecting speech and potentially other aspects of movement.
This test is particularly important for individuals showing symptoms of DYT4 dystonia or those with a family history of the condition, as it can provide definitive diagnosis, guide treatment options, and inform family planning decisions.
The TUBB4A gene DYT4 genetic test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the detailed, personalized insights it offers into a patient's genetic makeup. By opting for this test at DNA Labs UAE, individuals can expect professional service, accurate results, and comprehensive support throughout the testing process.
The GCH1 Gene DYT5A Genetic Test is a specialized diagnostic tool designed to identify mutations in the GCH1 gene, which are associated with DYT5A, also known as Segawa syndrome or dopa-responsive dystonia. This condition is a rare, inherited disorder characterized by dystonia, tremors, and issues with gait that typically responds well to treatment with levodopa, a medication commonly used to treat Parkinson's disease. The test involves analyzing the patient's DNA to detect any genetic variations in the GCH1 gene that may lead to the development of DYT5A.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test provides crucial information for the accurate diagnosis and management of individuals suspected to have dopa-responsive dystonia. With a cost of 4400 AED, the test is an investment in gaining a comprehensive understanding of the genetic underpinnings of the condition, which can significantly impact treatment decisions and outcomes. DNA Labs UAE employs cutting-edge technology and expertise to ensure reliable and accurate test results, making it a trusted choice for patients and healthcare providers seeking genetic testing services.
The THAP1 Gene DYT6 Genetic Test is a specialized diagnostic tool designed to identify mutations in the THAP1 gene, which are associated with DYT6 dystonia. DYT6 dystonia is a type of dystonia, a movement disorder that causes involuntary muscle contractions, leading to repetitive movements or abnormal postures. This particular form of dystonia is often hereditary and can affect various parts of the body, including the limbs, neck, and face.
The test is particularly valuable for individuals who have a family history of DYT6 dystonia or who exhibit symptoms suggestive of the condition. Early and accurate diagnosis through the THAP1 Gene DYT6 Genetic Test can significantly aid in the management and treatment of the disorder, potentially improving the quality of life for those affected.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing a sample of the patient's DNA to look for specific mutations in the THAP1 gene. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in the field of genetic diagnostics, ensuring high accuracy and reliability of test results.
The cost of the THAP1 Gene DYT6 Genetic Test at DNA Labs UAE is 4400 AED. While the cost may seem significant, the investment in such a diagnostic test can be invaluable for those affected by DYT6 dystonia, offering insights into treatment options and helping to manage the disorder more effectively.
The SLC2A1 gene, also known as the solute carrier family 2 member 1 gene, plays a crucial role in the human body by facilitating the transport of glucose across the blood-brain barrier. Mutations in the SLC2A1 gene are associated with various neurological disorders, including DYT8, also known as Paroxysmal Exercise-Induced Dyskinesia (PED). This condition is characterized by abnormal, involuntary movements triggered by physical exertion or prolonged exercise.
The DYT8 genetic test specifically looks for mutations in the SLC2A1 gene to confirm a diagnosis of PED. This test is crucial for individuals exhibiting symptoms of DYT8, as it helps in the accurate diagnosis and management of the condition. Early detection through genetic testing can lead to better management of symptoms and improve the quality of life for those affected.
In the United Arab Emirates, DNA Labs UAE offers the SLC2A1 gene DYT8 genetic test. The cost of the test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals experienced in genetic diagnostics. They ensure that the testing process is efficient and results are accurate and reliable, providing crucial information for patients and their families dealing with DYT8.
